266 related articles for article (PubMed ID: 9539769)
21. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
van Noort JM; Jacobs MJ
Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
[TBL] [Abstract][Full Text] [Related]
22. MHC class II molecules on the move for successful antigen presentation.
Rocha N; Neefjes J
EMBO J; 2008 Jan; 27(1):1-5. PubMed ID: 18046453
[TBL] [Abstract][Full Text] [Related]
23. Expression of cathepsins B, L, S, and D by gastric epithelial cells implicates them as antigen presenting cells in local immune responses.
Barrera C; Ye G; Espejo R; Gunasena S; Almanza R; Leary J; Crowe S; Ernst P; Reyes VE
Hum Immunol; 2001 Oct; 62(10):1081-91. PubMed ID: 11600214
[TBL] [Abstract][Full Text] [Related]
24. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
25. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
26. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
[TBL] [Abstract][Full Text] [Related]
27. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
28. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain.
Bodmer H; Viville S; Benoist C; Mathis D
Science; 1994 Mar; 263(5151):1284-6. PubMed ID: 7510069
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
30. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice.
Zhang T; Maekawa Y; Hanba J; Dainichi T; Nashed BF; Hisaeda H; Sakai T; Asao T; Himeno K; Good RA; Katunuma N
Immunology; 2000 May; 100(1):13-20. PubMed ID: 10809954
[TBL] [Abstract][Full Text] [Related]
31. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells.
Fiebiger E; Meraner P; Weber E; Fang IF; Stingl G; Ploegh H; Maurer D
J Exp Med; 2001 Apr; 193(8):881-92. PubMed ID: 11304549
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin S required for normal MHC class II peptide loading and germinal center development.
Shi GP; Villadangos JA; Dranoff G; Small C; Gu L; Haley KJ; Riese R; Ploegh HL; Chapman HA
Immunity; 1999 Feb; 10(2):197-206. PubMed ID: 10072072
[TBL] [Abstract][Full Text] [Related]
33. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
34. High efficiency of endogenous antigen presentation by MHC class II molecules.
Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977
[TBL] [Abstract][Full Text] [Related]
35. The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.
Gradehandt G; Ruede E
Immunology; 1991 Nov; 74(3):393-8. PubMed ID: 1769688
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin S activity regulates antigen presentation and immunity.
Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
[TBL] [Abstract][Full Text] [Related]
37. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
38. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
[TBL] [Abstract][Full Text] [Related]
39. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
[TBL] [Abstract][Full Text] [Related]
40. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
